8 articles on longevity & nad+ in Recovery & Longevity.
What is publicly known about Emideltide, an obscure research-stage peptide with very limited published literature, its possible relationship to delta-sleep peptide research, and its FDA transitional regulatory status as of April 2026.
What the research says about Epitalon (Ala-Glu-Asp-Gly), the Khavinson tetrapeptide. Telomerase research, pineal regulation, and FDA Category 2 status.
MOTS-C is a mitochondria-derived peptide that regulates metabolic signaling in preclinical research. Here is what the science actually says, what the regulatory status means, and how this peptide fits into the broader landscape of supervised wellness programs.
What researchers know about MOTS-c protocol design — dose ranges studied in preclinical models, timing considerations, and the current state of human evidence. Educational overview only.
What the research says about MOTs-c, the mitochondrial-derived peptide encoded in 12S rRNA: AMPK pathway activation, insulin sensitivity, exercise-mimetic action, and US transitional regulatory status.
What the research says about NAD+, how this coenzyme supports cellular energy, DNA repair, and sirtuin activity. Mechanism, current research evidence, and honest limits of human trial data.
NAD+ therapy supports cellular energy and repair by replenishing a coenzyme that declines with age. Learn what NAD+ therapy is, how it works, what the evidence says, and how a clinician-supervised protocol is structured.
NAD therapy uses intravenous or subcutaneous NAD+ to replenish declining cellular cofactor levels. This guide covers the science, administration routes, expected effects, and how clinician-supervised NAD therapy differs from oral supplements.
Ready when you are
Take a 3-minute assessment and a licensed clinician will recommend the right protocol for you — compounded in the USA by licensed 503A pharmacies.